Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: Hologic | Vintage Vibes

Hologic Stock at 52-Week High in 2026: Buy or Sell Ahead of $18.3 Billion Blackstone Takeover Closure?

Hologic Inc. shares hit a fresh 52-week high of $76.07 Tuesday as the medical technology company's $18.3 billion buyout by private equity giants Blackstone and TPG appeared on track to close as early as April 7, leaving investors with a narrow window to decide whether to buy, sell or ride…

International Business Times

Is Hologic Stock Outperforming the Dow?

Although Hologic has exceeded the Dow over the past year, analysts remain cautious about the stock’s prospects.

Barchart

Is Wall Street Bullish or Bearish on Hologic Stock?

Though Hologic has outperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What You Need To Know Ahead of Hologic's Earnings Release

Hologic is scheduled to release its first-quarter results soon, with analysts projecting single-digit growth in its bottom line figure.

Barchart

Is Hologic Stock Outperforming the Nasdaq?

While Hologic has underperformed the Nasdaq over the past year, it has notably outperformed in recent months, but analysts still remain cautious about the stock’s prospects.

Barchart

Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups

Benzinga

Hologic Agrees To $18.3 Billion Buyout By Blackstone And TPG

Hologic, Inc. (NASDAQ:HOLX) shares are trading higher after the company agreed to be acquired by funds managed by Blackstone Inc. (NYSE:BX) and TPG Inc. (NASDAQ:TPG) for an enterprise value of about $18.3 billion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What to Expect From Hologic’s Next Quarterly Earnings Report

Hologic is set to release its fourth-quarter earnings next month, and analysts are forecasting a solid high-single-digit increase in profits.

Barchart

Is Hologic Stock Underperforming the S&P 500?

Hologic has underperformed the broader S&P 500 index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

Barchart

What Are Wall Street Analysts' Target Price for Hologic Stock?

Although Hologic has underperformed the broader market over the past year, it has observed significant gains in recent months, and analysts are turning more optimistic on the stock’s prospects.

Barchart

How Is Hologic’s Stock Performance Compared to Other Health Care Equipment Stocks?

Hologic has outpaced its healthcare equipment peers over the past year, with analysts maintaining a moderately bullish outlook on the stock’s future performance.

Barchart

Here's What to Expect From Hologic’s Next Earnings Report

Hologic is scheduled to release its first-quarter results next month, and analysts are projecting single-digit dip in its bottom-line figure.

Barchart

Hologic Stock: Is HOLX Underperforming the Healthcare Sector?

Hologic has notably underperformed the healthcare sector over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Barchart

Hologic Stock: Analyst Estimates & Ratings

Hologic has observed a significant drop in stock prices recently and analysts are taking a more cautious stance on the company’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Earnings Preview: What To Expect From Hologic's Report

Hologic is scheduled to release its first-quarter results next month, with analysts projecting single-digit growth in its bottom line figure.

Barchart

Is Hologic Stock Underperforming the Dow?

Hologic has lagged behind the Dow index over the past three months, yet analysts remain cautiously optimistic about the stock's growth potential.

Barchart

Do Wall Street Analysts Like Hologic Stock?

Hologic has underperformed the broader market over the past year, but Wall Street analysts are moderately optimistic about the stock’s future.

Barchart

Hologic's Quarterly Earnings Preview: What You Need to Know

Hologic is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Hologic Stock Outperforming the Nasdaq?

Hologic has recently outperformed in the Nasdaq, and Wall Street analysts are moderately bullish about the stock’s prospects.

Barchart

Hologic's Q3 2024 Earnings: What to Expect

Hologic is expected to report its third-quarter earnings results this month, and Wall Street analysts expect a single-digit profit growth.

Top News

FDA Warns Of Potential Risk From Hologic Soft Tissue Devices

FDA warns of complications with Hologic's soft tissue medical devices, urging vigilance and reporting.

The Independent UK

Women in low-income households are less likely to receive the health care they need

Results have shown lower-earning women are less likely to receive preventative health care and more likely to give up work as a result of chronic pain

Wales Online

Women in low-income households are less likely to access healthcare, study finds

Women in households earning up to £25k per annum are less health literate - and less likely to understand healthcare professionals

The Independent UK

Sloane Stephens keen and candid about the subject of women’s health

The WTA is pushing for advancement in women’s healthcare through its partnership with Hologic

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022

Upgrades

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.